June 5, 2009 (Boston, Massachusetts) — A phase 3 study of belatacept vs cyclosporine (CsA) shows that at 1 year, belatacept appears to be associated with better preservation of renal function and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback